Evren, a clinical-stage medical device company, will transform treatment of Post-Traumatic Stress Disorder (PTSD) with a noninvasive bioelectronic medicine (e.g., neuromodulation) solution. They have a portable device for this major, urgent, and unmet need for effective treatment in a $19 billion market.